Try our Advanced Search for more refined results
Public Policy
-
March 04, 2026
Unions Sue Trump Over Moves To Ease Civil Servants' Firing
The Trump administration cannot strip tens of thousands of federal workers of their job protections without violating their right to due process and treading on Congress' territory, a coalition of labor groups argued Wednesday, filing their latest challenge to the administration's quest to make federal workers easier to fire.
-
March 04, 2026
Insurance Execs' Coverage Bid 'Not Plausible,' Judge Says
Berkley Assurance Co. doesn't owe any coverage duties to insurance executives who were sued over allegations they sabotaged their former company on their way out the door to start a rival firm, a Georgia federal judge has ruled.
-
March 04, 2026
Conn. Resident Asserts Dormant Commerce Cannabis Suit
A would-be cannabis grower challenging Connecticut's marijuana licensing program urged a federal judge not to toss his claims that the state's social equity licensure scheme is discriminatory, asserting that even as a resident of the state, he has an injury that gives him standing to sue.
-
March 04, 2026
Real Estate Owner Seeks Probation For $5M Tax Evasion
A commercial real estate owner found guilty of hiding nearly $5 million in income from the Internal Revenue Service asked a Washington federal court for a sentence of home confinement, saying he has changed his family business to eliminate the chances he will file false or late returns.
-
March 04, 2026
BREAKING: CIT Judge Orders All IEEPA Tariffs Be Refunded
The U.S. government must refund any tariff charged under President Donald Trump's now-struck-down International Emergency Economic Powers Act tariff regime, regardless of whether the affected company filed suit at the U.S. Court of International Trade seeking a refund, a CIT judge ordered Wednesday.
-
March 04, 2026
DC Judge Strikes Down 340B Drug Discount Registration Rule
The U.S. Health Resources and Services Administration cannot reinstate a pre-pandemic policy requiring covered hospitals' offsite facilities to register with the agency in order to access discounted drugs under the 340B program, a D.C. federal judge ruled.
-
March 04, 2026
11th Circ. Shouldn't Apply 3M Ruling To Coke, Gov't Says
The Eleventh Circuit should not apply the reasoning used by the Eighth Circuit in its October ruling for 3M Co. to allow Coca-Cola to indefinitely defer taxes it owes under IRS transfer pricing regulations, the U.S. government said Wednesday.
-
March 04, 2026
Chuckwalla Case To Stay in Michigan As Tribes Join Fight
A Michigan federal judge has decided that transferring a miner's case challenging the establishment of the Chuckwalla National Monument out of her court is "not inappropriate," while also ruling that a slew of tribal nations and environmental groups may intervene in the lawsuit.
-
March 04, 2026
Judge Invites Group Relief For ICE's 'Abhorrent' Actions
A Trump-appointed New York federal judge described the administration's arrest and detention of a Honduran with legal status as "a reprehensible act of unimaginable cruelty," saying the issue is widespread and suggesting the case could be broadened to a larger group.
-
March 04, 2026
Sandoz Parent Targets Walmart, Southwest Generic Drug Suits
Sandoz parent company Sandoz AG contested generic drug price-fixing complaints from Southwest Airlines, Walmart, Walgreen and United Healthcare, arguing that the direct action plaintiffs cannot pursue the company in the wider Pennsylvania federal court multidistrict litigation because the Swiss firm is too far removed from its Sandoz Inc. subsidiary.
-
March 04, 2026
Retirees' TIAA Rollover Advice Fee Suit Trimmed
A New York federal judge on Wednesday narrowed a proposed class action alleging the Teachers Insurance Annuity Association of America and its affiliates violated federal benefits law by coercing retirees into higher-cost managed accounts, holding individual retirees lacked standing to sue on behalf of participants in thousands of other plans.
-
March 04, 2026
BLM, Energy, FERC Nominees Clear Senate Committee
The U.S. Senate Energy and Natural Resources Committee on Wednesday approved former New Mexico Republican Congressman Steve Pearce to lead the Bureau of Land Management by an 11-9 vote, advancing that nominee to the full Senate for consideration in addition to two others.
-
March 04, 2026
DOJ Seeks Power To Block State Bar Probes Of Agency Attys
The U.S. Department of Justice is seeking to pause and review state-level ethics complaints against its attorneys to combat what the agency called "weaponization" of ethics processes, a proposal that drew concerns from ethics scholars for overstepping states' authorities.
-
March 04, 2026
Comey, James Urge 4th Circ. To Reject Indictment Revival Bid
Former FBI Director James Comey and New York Attorney General Letitia James have urged the Fourth Circuit not to revive criminal indictments filed against them last year in the Eastern District of Virginia, arguing they were fatally flawed because they were brought by a federal prosecutor who was not lawfully in that position.
-
March 04, 2026
FERC Can't Justify Nixing Grid-Planning Change, DC Circ. Told
The Federal Energy Regulatory Commission failed to justify its rejection of a PJM Interconnection plan to make grid-planning decisions without the approval of the regional grid operator's members committee, transmission owners told the D.C. Circuit on Tuesday.
-
March 04, 2026
NYC Wants To Nix Uber, DoorDash Challenge To Tipping Laws
Two New York City laws regulating how online platforms must display tipping options don't impinge on the companies' First Amendment rights, the city told a New York federal court, urging it to toss a challenge to the laws brought by Uber and DoorDash.
-
March 04, 2026
Buyers Finalize $58M Generic-Pricing Deal With 3 Drugmakers
Purchasers of certain generic drugs asked a Pennsylvania federal court for final approval of settlements worth a total of at least $58 million with Glenmark Pharmaceutical Inc., Greenstone LLC and Pfizer Inc. over claims the companies colluded with others to keep drug prices high.
-
March 04, 2026
Judge To Await Appellate Guidance In Immigrant Bond Case
A Massachusetts federal judge hearing a challenge to the Trump administration's policy of detaining unauthorized immigrants without bond during removal proceedings said Wednesday she is "inclined to wait" to issue a ruling until appellate courts weigh in.
-
March 04, 2026
Appeals Panel Debates NJ's Duty In Prosecutor Ethics Case
A New Jersey appellate panel on Wednesday weighed whether it was in the state's best interest to represent an assistant prosecutor in an ethics proceeding, questioning how a prosecutor is different from any other attorney called before the disciplinary board.
-
March 04, 2026
Club's Booze License Shouldn't Have Been Nixed, Court Says
An Atlanta adult entertainment club's alcohol license should not have been revoked, a Georgia appeals court ruled, finding that the city didn't provide enough evidence of prior code violations to support that penalty.
-
March 04, 2026
Judge Sets 'Hard Deadline' To Rule On Childhood Vax Policy
A Massachusetts federal judge said Wednesday he will rule within two weeks on a closely watched request to block the Centers for Disease Control and Prevention from paring back the recommended childhood vaccine schedule.
-
March 04, 2026
Enviro Groups Fight Montana Mine Expansion Approval
Conservation groups are looking to vacate the federal government's approval of operation expansion plans for a Montana coal mine at the center of years worth of past litigation, telling a federal court that the agencies "make a mockery of the required environmental review process."
-
March 04, 2026
Philly To Pay $750K, Revamp 'Courtesy Towing' Policies
The city of Philadelphia has agreed to pay $750,000 to resolve class claims over its "courtesy towing" program, which involves moving legally parked vehicles to other spots where they could be lost or subject to fines, according to settlement agreement.
-
March 04, 2026
House Panel Tussles Over Minnesota Medicaid Fraud Claims
The public political battle between Minnesota and the federal government over alleged Medicaid fraud in the state continued Wednesday on Capitol Hill, with Republicans and Democrats casting stones at each other after President Donald Trump's administration pulled nearly $260 million in healthcare funding from the state.
-
March 04, 2026
How AI's Power Surge Is Rewriting Energy Deal Strategy
The surge in electricity demand from artificial intelligence and data centers is redrawing the U.S. energy investment map, tilting capital back toward natural gas even as global dealmakers continue to deploy billions into renewable platforms.
Editor's Picks
-
Trump's Legal Battles
States, federal employee unions, various advocacy groups and several individuals have filed over 220 lawsuits challenging the Trump administration's implementation of executive orders and other initiatives. Law360 has created a database of those lawsuits, separated into categories based on their subject matter.
Expert Analysis
-
Compliance Takeaways Amid Subscription Practices Scrutiny
The Federal Trade Commission's prioritization of enforcement regarding deceptive billing and cancellation practices in recurring subscriptions, and new click-to-cancel rulemaking expected on the horizon, carry key takeaways for companies using recurring subscriptions to sell products or services, say attorneys at Arnold & Porter.
-
Series
Law School's Missed Lessons: In Court, It's About Storytelling
Law school provides doctrine, cases and hypotheticals, but when lawyers step into the courtroom, they must learn the importance of clarity, credibility, memorability and preparation — in other words, how to tell simple, effective stories, say Nicholas Steverson and Danielle Trujillo at Wheeler Trigg, and Lisa DeCaro at Courtroom Performance.
-
How Leveraged Lending Pivot May Alter Bank Risk Oversight
The Federal Deposit Insurance Corp. and Office of the Comptroller of the Currency's recent withdrawal of leveraged lending guidance introduces several principles that may allow banks to better apply enterprisewide risk management programs and potentially create additional competition in the private credit loan market, say attorneys at Mayer Brown.
-
Pros And Cons Of FDA's Push For Nonprescription Drugs
The U.S. Food and Drug Administration's recent moves to shift more prescription drugs to over-the-counter status could increase access to important medications, but also bring potential safety risks and other trade-offs for drug companies, say attorneys at Hogan Lovells.
-
Why SDNY May Be Dusting Off The Financial Kingpin Statute
The Southern District of New York’s recent fraud indictments against executives of bankrupt companies Tricolor and First Brands have seemingly revived the Continuing Financial Crimes Enterprise statute, and if the cases succeed, prosecutors across the country will have ample reason to reach for this long-dormant tool, say attorneys at Lankler Siffert & Wohl.
-
What's Changed In Army Corps' Reissued Nationwide Permits
The final rule recently issued by the U.S. Army Corps of Engineers, renewing and revising nationwide permits for projects covered by Section 404 of the Clean Water Act, makes measured adjustments rather than sweeping revisions, addressing key operational and compliance concerns while maintaining the existing framework, say attorneys at Spencer Fane.
-
What Kalshi Cases Reveal About State Authority, Regulation
Prediction markets like Kalshi have ignited complex legal battles that get to the heart of how novel financial products intersect with traditional state enforcement authority, and courts are already beginning to divide over whether federal law preempts state enforcement authority restricting these offerings, say attorneys at Holtzman Vogel.
-
Parsing Clarifications On Foreign Entity Rules For Tax Credits
Recent U.S. Internal Revenue Service and Treasury Department guidance answers taxpayer questions on several key foreign entity rules under the One Big Beautiful Bill Act, but questions remain over transactions with companies that have ties to covered nations such as Iran, say attorneys at Cleary.
-
What US Arms Sales Reforms Mean For Defense Industry
A recent executive order with the goal of increasing U.S. arms sales transparency, speed and government-industry collaboration carries both promise and risk for the defense industry as the government seeks to leverage the private sector and use commercial products for defense purposes, say attorneys at Fluet.
-
Prepping For The Future Of No Surprises Act Enforcement
This year is expected to be a transition point for the No Surprises Act framework from regulatory delay to operational enforcement, so stakeholders should use this time to stress-test systems, clean up processes and prepare for enforcement, say attorneys at Akerman.
-
A Tale Of 2 Self-Disclosure Policies: How SDNY, DOJ Differ
Though the U.S. Attorney’s Office for the Southern District of New York’s recently announced corporate enforcement and voluntary self-disclosure policy shares many similarities with that of the U.S. Department of Justice, the two programs differ in meaningful ways, including subject matter scope and timeline to declination, say attorneys at Wiley.
-
Aligning Microsoft Tools With NYC Bar AI Recording Guidance
The New York City Bar Association’s recently issued formal opinion, providing ethical guidance on artificial intelligence-assisted recording, transcription and summarization, raises immediate questions about data governance and e-discovery for companies that use Microsoft 365 and Copilot, say Staci Kaliner, Martin Tully and John Collins at Redgrave.
-
What Employers Should Know About Calif. PAGA Proposal
Recently proposed regulations concerning the Private Attorneys General Act evidence an intent by California's Labor and Workforce Development Agency to play a greater role in the prosecution of PAGA actions, including more oversight over the exhaustion notices and settlement process, say attorneys at Paul Hastings.
-
FTC Focus: Antitrust Spotlight On 'Acqui-Hires,' Noncompetes
A recent Federal Trade Commission focus on labor issues, like 'acqui-hire' deals, in which only a company's workforce is acquired, and noncompetes, shows that the agency is scrutinizing these issues on a case-by-case basis, necessitating a meaningful look at these transactions, particularly in the technology and artificial intelligence industries, say attorneys at Proskauer.
-
FDA's Biosimilarity Guidance Holds Uncertain Implications
The U.S. Food and Drug Administration's new draft guidance aimed at simplifying the biosimilarity demonstration process may not be enough to overcome the barriers that have historically constrained biosimilar competition, and could affect biosimilar access in unexpected ways, say analysts at Analysis Group.